drugset / Trial / NCT00609128

Effect of Olopatadine on Allergic Tear Mediators

NCT00609128 ↗

NaSingle-groupOpen-labelBasic science

Summary

The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary redness, itching, tearing, and swelling of the eyes. Substances released by cells in the affected tissues cause allergic reactions in the eye and elsewhere in the body.

Timeline

Start
2000-09
Primary completion
2009-11
Completion
2009-11

Outcome

Met primary endpoint

paper Eosinophil adhesion to HCEs treated with tears from olopatadine-treated allergic subjects was inhibited (P < 0.01) compared with tear-stimulated adhesion observed from untreated eyes. PMID 16877412 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Olopatadine Other / unclassified — Topical

Indications